Remission Realized: Achieving Disease Control in Your Patients with Rheumatoid Arthritis : Episode 10
Guiding Treatment Decisions: The Role of Remission Data and Head-to-Head Comparisons
Panelists discuss how head-to-head clinical trial data shape their treatment decisions, the significance of consistent remission rates across different patient populations, and the frequency with which remission data influence their choices to switch therapies.
EP: 1.Intro and Welcomes
EP: 2.Evolving Goals in Rheumatoid Arthritis Treatment: Defining and Achieving Clinical Remission
EP: 3.Prevalence and Management of Poorly Controlled Rheumatoid Arthritis in Clinical Practice
EP: 4.Complications and Prognostic Factors in Uncontrolled Rheumatoid Arthritis
EP: 5.Evaluating and Adjusting Rheumatoid Arthritis Treatment: Adhering to ACR Guidelines for csDMARDs and Advanced Therapies
EP: 6.Exploring the Discrepancy Between Patient Perception and Disease Activity Assessments
EP: 7.Achieving Low Disease Activity and Remission: Managing Patient Expectations
EP: 8.Guidance on Transitioning from TNFi to Non-TNF Targeted Therapies
EP: 9.Advanced Treatment Options for RA: Exploring the Data
Now Viewing
EP: 10.Guiding Treatment Decisions: The Role of Remission Data and Head-to-Head Comparisons
EP: 11.JAK Inhibitors vs TNF Inhibitors: Effects on Administration, Efficacy, and Safety
EP: 12.JAK Inhibitor Selectivity and Dose-Related Toxicity
Video content above is prompted by the following:
- How do head-to-head data affect your treatment decisions?
- What does consistency of remission across patient types mean to you?
How often do you rely on remission data when considering switching therapies?
Recent Videos
Related Content
